The Journal of Immunology, Vol 138, Issue 1 98-103, Copyright © 1987 by American Association of Immunologists

ARTICLES

Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140

A Pezzutto, B Dorken, G Moldenhauer and EA Clark

The B cell-specific antigen CD22 is a 130/140-Kd complex and is unique among human B cell antigens, since its surface expression is restricted to a subpopulation of Ig+ B cells. Here the function of the CD22 antigen was evaluated by using the mAb HD6, directed against one of the epitopes on the molecule. The HD6 antibody was constimulatory with anti- Ig in inducing small, dense tonsillar cells to proliferate; however, the antibody by itself was devoid of stimulatory activity. Anti-CD22 antibody also induced more anti-Ig-treated B cells to leave G0 and enter the G1 phase of the cell cycle. It also was constimulatory with low-m.w. BCGF and with an antibody to a 50-Kd polypeptide, Bp50, which mediates a BCGF-like activity. Results of kinetic experiments and analysis of different B cell fractions suggested that anti-CD22 acts during an early phase of B cell activation, probably by amplifying the anti-Ig signal. F(ab')2 fragments of anti-CD22 HD6 were as effective as the whole antibody in inducing augmentation of B cell proliferation, showing that the Fc portion of the molecule was not required for the activity. The results of these experiments, together with the intriguing distribution of the Bp 130/140 antigen in B cell ontogeny, suggest that this molecule plays an important role in the process that leads to B cell activation and proliferation.

This article has been cited by other articles:

				A. Varki and T. Angata Siglecs--the major subfamily of I-type lectins Glycobiology, January 1, 2006; 16(1): 1R - 27R. [Abstract] [Full Text] [PDF]

				B. E. Collins, O. Blixt, N. V. Bovin, C.-P. Danzer, D. Chui, J. D. Marth, L. Nitschke, and J. C. Paulson Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22 Glycobiology, September 1, 2002; 12(9): 563 - 571. [Abstract] [Full Text] [PDF]

				K. L. Otipoby, K. E. Draves, and E. A. Clark CD22 Regulates B Cell Receptor-mediated Signals via Two Domains That Independently Recruit Grb2 and SHP-1 J. Biol. Chem., November 16, 2001; 276(47): 44315 - 44322. [Abstract] [Full Text] [PDF]

				J. Golay, L. Zaffaroni, T. Vaccari, M. Lazzari, G.-M. Borleri, S. Bernasconi, F. Tedesco, A. Rambaldi, and M. Introna Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis Blood, June 15, 2000; 95(12): 3900 - 3908. [Abstract] [Full Text] [PDF]

				T. Adachi, C. Wakabayashi, T. Nakayama, H. Yakura, and T. Tsubata CD72 Negatively Regulates Signaling Through the Antigen Receptor of B Cells J. Immunol., February 1, 2000; 164(3): 1223 - 1229. [Abstract] [Full Text] [PDF]

				J. M. Tuscano, A. Riva, S. N. Toscano, T. F. Tedder, and J. H. Kehrl CD22 Cross-Linking Generates B-Cell Antigen Receptor-Independent Signals That Activate the JNK/SAPK Signaling Cascade Blood, August 15, 1999; 94(4): 1382 - 1392. [Abstract] [Full Text] [PDF]

				S. G. Tangye, J. Wu, G. Aversa, J. E. de Vries, L. L. Lanier, and J. H. Phillips Cutting Edge: Negative Regulation of Human T Cell Activation by the Receptor-Type Protein Tyrosine Phosphatase CD148 J. Immunol., October 15, 1998; 161(8): 3803 - 3807. [Abstract] [Full Text] [PDF]

				K. G.C. Smith, D. M. Tarlinton, G. M. Doody, M. L. Hibbs, and D. T. Fearon Inhibition of the B Cell by CD22: A Requirement for Lyn J. Exp. Med., March 2, 1998; 187(5): 807 - 811. [Abstract] [Full Text] [PDF]

				T. L. O'Keefe, G. T. Williams, S. L. Davies, and M. S. Neuberger Hyperresponsive B Cells in CD22-Deficient Mice Science, November 1, 1996; 274(5288): 798 - 801. [Abstract] [Full Text]

				L. D. Powell, R. K. Jain, S. Sabesan, and A. Varki Characterization of Sialyloligosaccharide Binding by Recombinant Soluble and Native Cell-associated CD22 J. Biol. Chem., March 31, 1995; 270(13): 7523 - 7532. [Abstract] [Full Text] [PDF]

				R. Schulte, M. Campbell, W. Fischer, and B. Sefton Tyrosine phosphorylation of CD22 during B cell activation Science, November 6, 1992; 258(5084): 1001 - 1004. [Abstract] [PDF]